Collection of Circulating Biomarkers in Pancreatic Cancer
Recruiting · NCT05743049 · Observational (researchers observe without assigning treatment) · Lead sponsor: Abramson Cancer Center at Penn Medicine
View the official record on ClinicalTrials.gov →Interventions studied
Obtaining blood for analysis of various circulating biomarkers
What this trial is about
This protocol will involve collection of blood samples from patients with a diagnosis of pancreatic adenocarcinoma for evaluation of circulating biomarkers.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- The subject must have a known or presumed diagnosis of pancreatic adenocarcinoma
- The subject must be a patient of the University of Pennsylvania
- The subject must be able to provide informed consent
- The subject must be 18 years of age or older
Exclusion criteria
- Subjects who have any clinically significant psychiatric, social, or medical condition that, in the opinion of the investigator, could increase the patient's risk, interfere with protocol adherence, or affect the patient's ability to give informed consent are ineligible to participate in the study.
Where it is running
1 location listed across 1 US state.
- Abramson Cancer Center at University of Pennsylvania - Philadelphia, Pennsylvania, United States